Evalueserve

DECEMBER 6, 2021

Within the healthcare industry, healthcare equipment continues to outperform (refer to the graph below) driven by the urgent need for innovative care delivery in new or alternative settings and expedited recovery of demand especially for elective procedures. Global Healthcare Capital Markets Activity.

Capital 98

Capital Globalization Biotech Marketing 98

Alpha Sense BI

FEBRUARY 8, 2023

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices — as well as their intentions to scale their digital health solutions — to the masses in hopes of securing capital.

Biotech 96

Biotech Research Innovation Capital 96

Owler

MAY 17, 2023

Worldia’s product and the company’s resilience impressed investors like Credit Mutuel Innovation , who led the Series B funding round. Series A Funding Round Results in $59M for Taichu Biotech A China-based provider of drug development and evaluation services for the biopharmaceutical industry, Taichu Biotech raised $59M in funds.

Biotech 52

Biotech Travel Capital Entertainment 52

CIO

DECEMBER 27, 2023

The Netherlands The Netherlands is home to a rapidly growing tech industry, in particular, in Amsterdam, which boasts several innovation hubs, according to EuroNews. The innovation hubs include Amsterdam Science Park’s Startup Village, VU Starthub, and LAB42, which is a digital innovation hub located at the University of Amsterdam.

Startups 860

Startups Biotech Capital Innovation 860

Alpha Sense BI

MAY 5, 2023

Around the world, investors are favoring companies that have proven their profitability and that can demonstrate how they have successfully utilized their capital. M&A Trends by Industry Healthcare The COVID-19 pandemic ushered in a wave of unprecedented innovation, progress, and transformation to the healthcare industry in 2020.

Biotech 97

Biotech Capital Banking Startups 97

Alpha Sense BI

APRIL 29, 2024

Heading into the second half of 2024, venture capital investors remain cautious as they acknowledge persistent challenging dynamics in the landscape. While dry powder reserves have reached record highs, investors are wary about deploying capital with certain recent macroeconomic factors still fresh in mind.

Capital 52

Capital Due Diligence Biotech Startups 52

Wink Intel

FEBRUARY 23, 2021

tech and biotech ETFs and two fixed income components. With a twofold focus on technology, both in its design and in its equity thematic, this innovative index aims at providing investors with an opportunity for consistent performance across various market cycles.”.

Intellectual Property 40

Intellectual Property Biotech Banking Retail 40